Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:10 AM
Study NCT ID:
NCT05663827
Status:
COMPLETED
Last Update Posted:
2024-03-05
First Post:
2022-11-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ruxolitinib as add-on Therapy in Steroid-refractory Graft-vs-host Disease
Sponsor:
Yi-Lun Wang
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2022-11-23
First Submit QC Date:
None
Study First Post Date:
2022-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-02
Last Update Post Date:
2024-03-05
Last Update Post Date Type:
ACTUAL